Real-time enrollment status for this human papilloma virus (hpv) clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 3:07 AM UTC
| NCT Number | NCT07601074 |
| Recruiting Status | Recruiting |
| Condition | Human Papilloma Virus (HPV) |
| Phase | PHASE2 |
| Target Enrollment | 118 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Daré Bioscience, Inc. |
| Last Updated on CT.gov | October 20, 2026 (Yesterday) |
As of October 21, 2026: Clinical trial NCT07601074 is currently recruiting participants. This phase2 study for human papilloma virus (hpv) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Daré Bioscience, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07601074 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07601074 was last updated Yesterday (October 20, 2026). HelloStudys verifies this status automatically.